Zimmer Biomet Prices $1.75 Billion Debt Offering
Ticker: ZBH · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1136869
Sentiment: neutral
Topics: debt-offering, financing, notes
Related Tickers: ZBH
TL;DR
ZBH just raised $1.75B in new debt – 5.25% notes due '34 & 5.625% notes due '54.
AI Summary
On August 15, 2024, Zimmer Biomet Holdings, Inc. entered into a material definitive agreement related to the issuance of new debt. Specifically, the company announced the pricing of its offering of $1.0 billion aggregate principal amount of 5.250% notes due 2034 and $750 million aggregate principal amount of 5.625% notes due 2054.
Why It Matters
This debt issuance indicates Zimmer Biomet is raising significant capital, likely for general corporate purposes or strategic initiatives, which could impact its financial leverage and future investments.
Risk Assessment
Risk Level: medium — Issuing substantial new debt increases financial leverage and interest expense, which can pose risks if the company's future earnings do not support the obligations.
Key Numbers
- $1.75 billion — Total Debt Offering (Aggregate principal amount of notes issued.)
- 5.250% — Interest Rate (2034 Notes) (Coupon rate for the notes due in 2034.)
- 5.625% — Interest Rate (2054 Notes) (Coupon rate for the notes due in 2054.)
Key Players & Entities
- ZIMMER BIOMET HOLDINGS, INC. (company) — Registrant
- August 15, 2024 (date) — Date of earliest event reported
- $1.0 billion (dollar_amount) — Principal amount of 5.250% notes due 2034
- $750 million (dollar_amount) — Principal amount of 5.625% notes due 2054
FAQ
What is the total principal amount of the debt offering?
The total principal amount of the debt offering is $1.75 billion, comprising $1.0 billion of notes due 2034 and $750 million of notes due 2054.
What are the maturity dates for the new notes?
The new notes have maturities in 2034 (5.250% notes) and 2054 (5.625% notes).
What is the purpose of this debt issuance?
The filing states the proceeds are intended for general corporate purposes, which may include funding strategic initiatives, acquisitions, or refinancing existing debt.
When was the pricing of these notes announced?
The pricing of the notes was announced on August 15, 2024.
What is the interest rate on the longer-term notes?
The interest rate on the notes due 2054 is 5.625%.
Filing Stats: 1,184 words · 5 min read · ~4 pages · Grade level 10 · Accepted 2024-08-15 16:16:04
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value ZBH New York Stock Exchan
- $700,000,000 — ed its previously announced issuance of $700,000,000 aggregate principal amount of the Compa
Filing Documents
- d819738d8k.htm (8-K) — 38KB
- d819738dex42.htm (EX-4.2) — 114KB
- d819738dex51.htm (EX-5.1) — 20KB
- g819738g88a57.jpg (GRAPHIC) — 3KB
- g819738g88e99.jpg (GRAPHIC) — 1KB
- 0001193125-24-201328.txt ( ) — 373KB
- zbh-20240815.xsd (EX-101.SCH) — 4KB
- zbh-20240815_def.xml (EX-101.DEF) — 13KB
- zbh-20240815_lab.xml (EX-101.LAB) — 23KB
- zbh-20240815_pre.xml (EX-101.PRE) — 14KB
- d819738d8k_htm.xml (XML) — 7KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 4.1 Indenture, dated as of November 17, 2009, between Zimmer Holdings, Inc. (now known as Zimmer Biomet Holdings, Inc.) and Computershare Trust Company, N.A., as successor to Wells Fargo Bank, National Association, as trustee ( incorporated by reference to Exhibit 4.1 to the Registrant ' s Current Report on Form 8-K filed December 13, 2016 ). 4.2 Tenth Supplemental Indenture, dated as of August 15, 2024, between Zimmer Biomet Holdings, Inc. and Computershare Trust Company, N.A., as trustee. 4.3 Form of 5.200% Notes due 2034 ( included in Exhibit 4.2 ). 5.1 Opinion of Faegre Drinker Biddle & Reath LLP. 23.1 Consent of Faegre Drinker Biddle & Reath LLP (include in Exhibit 5.1 hereto). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 15, 2024 ZIMMER BIOMET HOLDINGS, INC. By: /s/ Chad F. Phipps Name: Chad F. Phipps Title: Senior Vice President, General Counsel and Secretary